Patent ID: 11945812
Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 21:
22. The compound or salt according to claim 1, wherein
R5 is Ra1;
Ra1 is selected from the group consisting of 3-11 membered heterocyclyl and 5-10 membered heteroaryl, wherein the 3-11 membered heterocyclyl and 5-10 membered heteroaryl are all optionally substituted with one or more, identical or different Rb1 and/or Rc1;
each Rb1 is independently selected from the group consisting of —ORc1, —NRc1Rc1, halogen, —C(═O)ORc1 and the bivalent substituent ═O;
each Rc1 is independently selected from the group consisting of hydrogen, C1-6alkyl, C1-6haloalkyl, C3-10cycloalkyl and 3-11 membered heterocyclyl, wherein the C1-6alkyl, C1-6haloalkyl, C3-10cycloalkyl and 3-11 membered heterocyclyl are all optionally substituted with one or more, identical or different Rd1 and/or Re1;
each Rd1 is independently selected from the group consisting of —ORe1, —NRe1Re1 and halogen;
each Re1 is independently selected from the group consisting of hydrogen, C1-6alkyl, C3-10cycloalkyl and 3-11 membered heterocyclyl, wherein the C1-6alkyl, C3-10cycloalkyl and 3-11 membered heterocyclyl are all optionally substituted with one or more, identical or different substituent(s) selected from the group consisting of C1-6alkyl and 3-11 membered heterocyclyl optionally substituted with one or more, identical or different C1-4alkyl.